These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7959421)

  • 1. [Effect of mesalazine microgranules on experimental colitis].
    Nakamaru K; Sugai T; Hongyo T; Sato M; Taniguchi S; Tanaka Y; Kawase S
    Nihon Yakurigaku Zasshi; 1994 Oct; 104(4):303-11. PubMed ID: 7959421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and anti-inflammatory effect of mesalazine on carrageenan-induced colitis in the rabbit.
    Kitano A; Matsumoto T; Oshitani N; Nakagawa M; Yasuda K; Watanabe Y; Tomobuchi M; Obayashi M; Tabata A; Fukushima R; Okabe H; Nakamura S; Obata A; Okawa K; Kobayashi K
    Clin Exp Pharmacol Physiol; 1996 Apr; 23(4):305-9. PubMed ID: 8717066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease.
    Brogden RN; Sorkin EM
    Drugs; 1989 Oct; 38(4):500-23. PubMed ID: 2684592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.
    Clemett D; Markham A
    Drugs; 2000 Apr; 59(4):929-56. PubMed ID: 10804042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of slow release mesalazine.
    De Vos M
    Clin Pharmacokinet; 2000 Aug; 39(2):85-97. PubMed ID: 10976656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of mesalazine, an agent for the treatment of idiopathic inflammatory bowel disease, on reactive oxygen metabolites and LTB4 formation].
    Nakamaru K; Sugai T; Kinoshita N; Sato M; Taniguchi S; Kawase S
    Nihon Yakurigaku Zasshi; 1994 Dec; 104(6):447-57. PubMed ID: 7851818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effectiveness of rectally administered fish oil and mesalazine in trinitrobenzenesulfonic acid-induced colitis.
    Yorulmaz E; Yorulmaz H; Gökmen ES; Altınay S; Küçük SH; Zengi O; Çelik DS; Şit D
    Biomed Pharmacother; 2019 Oct; 118():109247. PubMed ID: 31351432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats.
    Hayashi Y; Aoyagi K; Morita I; Yamamoto C; Sakisaka S
    Scand J Gastroenterol; 2009; 44(11):1323-31. PubMed ID: 19891583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prophylactic effect of 5-aminosalicylic acid and salazosulphapyridine on degraded-carrageenan-induced colitis in guinea pigs.
    Jensen BH; Andersen JO; Poulsen SS; Skov Olsen P; Nørby Rasmussen S; Hansen SH; Hvidberg EF
    Scand J Gastroenterol; 1984 May; 19(3):299-303. PubMed ID: 6146186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.
    Ewe K; Becker K; Ueberschaer B
    Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: new developments in the use of 5-aminosalicylic acid in patients with inflammatory bowel disease.
    Thomson AB
    Aliment Pharmacol Ther; 1991 Oct; 5(5):449-70. PubMed ID: 1793778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacokinetic study of sulphasalazine and two new formulations of mesalazine.
    Swift GL; Mills CM; Rhodes J; Evans BK; Bennett A; Tavares IA
    Aliment Pharmacol Ther; 1992 Apr; 6(2):259-66. PubMed ID: 1350926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
    Vishwakarma N; Ganeshpurkar A; Pandey V; Dubey N; Bansal D
    Drug Deliv; 2015 Jan; 22(1):94-9. PubMed ID: 24491122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production.
    Gálvez J; Garrido M; Rodríguez-Cabezas ME; Ramis I; de Medina FS; Merlos M; Zarzuelo A
    Inflamm Bowel Dis; 2003 Nov; 9(6):363-71. PubMed ID: 14671485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol therapy following trinitrobenzene sulfonic acid-induced colitis accelerates healing.
    Torsher KJ; Empey LR; Fedorak RN
    Prostaglandins Leukot Essent Fatty Acids; 1992 Apr; 45(4):275-81. PubMed ID: 1603818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-amino salicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or mesalazine.
    Stretch GL; Campbell BJ; Dwarakanath AD; Yaqoob M; Stevenson A; Morris AI; Rhodes JM
    Aliment Pharmacol Ther; 1996 Dec; 10(6):941-7. PubMed ID: 8971292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal transit and release of mesalazine tablets in patients with inflammatory bowel disease.
    Healey JN
    Scand J Gastroenterol Suppl; 1990; 172():47-51. PubMed ID: 2353171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
    Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
    Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis.
    Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA
    Gastroenterology; 1988 Jun; 94(6):1383-9. PubMed ID: 2896139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.